News
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on ...
6h
Zacks Investment Research on MSNCVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?Retail pharmacy powerhouse, CVS Health CVS, is advancing its digital-first strategy and investing in emerging technologies as part of its long-term growth plan. The company recently announced plans to ...
A bill aimed at increasing transparency in how pharmacy benefit managers operate advanced out of the Senate Insurance ...
CVS and Express Scripts filed separate lawsuits challenging a new Arkansas law they say aims to put them out of business in the state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results